Neurovascular Intervention

Ischemic stroke is an acute cerebrovascular disease characterized by sudden interruption of blood flow in a certain part of the brain, leading to serious disability and death. At present, treatment methods for ischemic stroke are limited to thrombolysis or thrombus removal, but the treatment window is very narrow. However, recovery of cerebral blood circulation further causes cerebral ischemia/reperfusion injury (CIRI). The endoplasmic reticulum (ER) plays an important role in protein secretion, membrane protein folding, transportation, and maintenance of intracellular calcium homeostasis.

EXO-Hep significantly mitigated ischemic injury in a model of transient middle cerebral artery occlusion (tMCAO) by reducing the infarct area and improving neurological performance during the process of cerebral ischemia–reperfusion.

This randomized controlled trial is the first to directly compare safety and efficacy of coated flow diverters under SAPT with bare flow diverters under DAPT.

Ischemic stroke (IS), characterised by a typical acute cerebrovascular dysfunction, is among the major deadly ailments in middle-aged and aged individuals. Nonetheless, latest accessible efficient therapy choices are restricted and solely appropriate for a small variety of stroke sufferers. Urokinase and streptokinase are neuroprotective drug candidates which have been clinically utilized for the therapy of IS. Though these medicine can activate plasminogen to kind plasmin, they’ll additionally degrade coagulation components and fibrinogen. Due to this fact, they potentiate a excessive danger of bleeding when utilized in thrombolytic remedy.

Onset of seizures after stroke more than doubled the risk for dementia in young patients, according to a study published in Neurology.

First, the bad news. There are upwards of 800,000 strokes annually in the United States, an average of one every 45 seconds. Strokes are among the most common cause of adult disability in the United States and can have a devastating effect on patients’ quality of life.

Survivors of pediatric ischemic stroke are at increased risk for neurological disabilities such as epilepsy, cerebral palsy, and hemiplegia. ADHD had been reported among up to 50% of the pediatric ischemic stroke population; however, the level of risk for ADHD in pediatric stroke remains unclear.

Overall, EVT was not associated with improved clinical outcomes in mild strokes due to LVO, and sICH was increased. However, in patients with target mismatch profile, EVT was associated with increased functional independence. Perfusion imaging may be helpful to select mild stroke patients for EVT.

Stroke is a leading cause of morbidity and mortality worldwide. There have been significant advances in the hyperacute treatment of patients with ischemic stroke with the advent and application of reperfusion therapies, including intravenous thrombolysis and endovascular thrombectomy. Endovascular thrombectomy involves the removal of thrombus from an artery using a mechanical retriever or aspiration with angiographic visualization. This review aims to outline the current evidence to support the use of endovascular thrombectomy and highlight areas of ongoing research.

The risk of having a future stroke caused by a severe blockage in an artery in the neck that is not currently causing any symptoms is so low that most patients with this condition -; asymptomatic carotid stenosis -; could potentially be treated with the newest medications and may not require surgery, new Kaiser Permanente research suggests.

This randomized, double-blind, placebo-controlled study enrolled 206 patients with moderate to moderately severe ischemic stroke (baseline NIHSS 8-20) who received a single intravenous infusion within 18-36 hours of stroke onset MultiStem or placebo treatment.

Tea consumption is associated with a decreased risk of stroke, particularly ischemic stroke. More well-designed, rigorously conducted studies are needed in order to make confident conclusions about the association between tea consumption and stroke subtypes.

This study shows that enhanced soluble CD40L level is a predictor of vascular events in patients with nonvalvular AF, thus suggesting that enhanced platelet activation may play a role in its clinical progression.

The most recent findings published in Radiology were based on the MRI brain scans of 366 patients. Researchers found that as the presence of white matter hyperintensity (WMH) volumes increased, so too did patients’ risk of poor three-month functional outcomes after endovascular thrombectomy (EVT).

The study looked at three sizes of air pollution particulate matter. Particulate matter consists of liquids or solids suspended in air. Submicron particulate matter, PM1, is less than one micron in diameter and includes soot and smog. Fine particulate matter, PM2.5, is less than 2.5 microns in diameter and includes fly ash from coal combustion. Respirable particulate matter, PM10, is less than 10 microns in diameter and includes cement dust.

Acupuncture combined with herbal medicine is effective for the treatment of post-stroke aphasia. In one investigation, acupuncture plus herbal medicine produced superior treatment outcomes when compared with intravenous injections of edaravone. In another investigation, acupuncture plus speech therapy was found superior to using only speech therapy. Aphasia is a condition caused by brain damage that affects the ability to communicate through speech or written language. This affects both comprehension and expression.

Approximately 1‐in‐4 of anterior large vessel occlusion stroke patients undergoing EVT have an NIHSS score of <6 within 30 minutes of successful recanalization. Only 1% of them experience significant decline in neurological status within 24 hours of the procedure with the majority achieving functional independence at 90 days. The need for advanced neurocritical care should be reevaluated in these patients.

Brainomix’s e-Stroke platform has been widely implemented across the supraregional network, linking the Royal London Hospital with referring sites such as Colchester Hospital, Darent Valley Hospital, Maidstone Hospital, Kent & Canterbury Hospital, Ipswich Hospital, and Peterborough Hospital. “We now have the largest AI-enabled stroke network in the country, enabling us to quickly review images and make decisions across this large patch,” noted Dr Oliver Spooner, Consultant Stroke Physician, Barts Trust NHS Health.

1 in 4 stroke survivors will have another. Yet up to 80% of strokes may be prevented with a combination of medication and healthy habits, such as healthy diet and physical activity, that can have a big impact.

Stroke is dangerous and deadly — the No. 5 killer and a leading cause of disability in America. But you can control and treat several risk factors for stroke.

This research proposes a low-cost and simple operation microfluidic chip to enhance the magnetic labeling efficiency of two ischemic stroke biomarkers: cellular fibronectin (c-Fn) and matrix metallopeptidase 9 (MMP9). This fully portable and pump-free microfluidic chip is operated based on capillary attractions without any external power source and battery. It uses an integrated cellulose sponge to absorb the samples. At the same time, a magnetic field is aligned to hold the target labeled by the magnetic nanoparticles (MNPs) in the pre-concentrated chamber. By using this approach, the specific targets are labeled from the beginning of the sampling process without preliminary sample purification.

Ischemic stroke is the leading cause of long-term disability worldwide, affecting over 13 million people each year and costing tens of billions of dollars. Sensome, a French medtech that offers connected medical devices, has developed micrometric AI-powered impedance sensors that can identify the biological nature of the tissue they touch in real-time. Integration of this proprietary technology into a probe to guide medical devices in arteries (a guidewire) has given rise to Sensome’s first product, Clotild®, which recognizes blood clot types in ischemic strokes so clots can be treated faster to improve patients’ chances of a full recovery. The Sensome technology also helps transform the current standard of care in oncology.